---
title: "KZR.US (KZR.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KZR.US/news.md"
symbol: "KZR.US"
name: "KZR.US"
parent: "https://longbridge.com/en/quote/KZR.US.md"
datetime: "2026-05-20T16:20:43.119Z"
locales:
  - [en](https://longbridge.com/en/quote/KZR.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KZR.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KZR.US/news.md)
---

# KZR.US (KZR.US) — Related News

### [Kezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for Investors](https://longbridge.com/en/news/286043692.md)
*2026-05-12T06:01:35.000Z*
> Kezar Life Sciences (KZR) has disclosed a new risk in its Regulation category, directing investors to Part I of its fili

### [Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences](https://longbridge.com/en/news/285957581.md)
*2026-05-11T13:59:48.000Z*
> Aurinia Pharmaceuticals has completed the acquisition of approximately 80.24% of Kezar Life Sciences' outstanding common

### [Kevin Tang named CEO of Kezar Life Sciences as multiple directors and officers resign](https://longbridge.com/en/news/285953605.md)
*2026-05-11T13:33:01.000Z*
> Kezar Life Sciences has appointed Kevin Tang as the new Chief Executive Officer and sole director following the resignat

### [Kezar Life Sciences Announced Transfer or Voluntary Withdrawal of Listing](https://longbridge.com/en/news/285953600.md)
*2026-05-11T13:33:01.000Z*
> Kezar Life Sciences announced on May 11, 2026, that it has completed its merger and requested the suspension of trading 

### [Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Consensus Recommendation of "Reduce" by Analysts](https://longbridge.com/en/news/285171654.md)
*2026-05-05T08:12:39.000Z*
> Kezar Life Sciences, Inc. (NASDAQ:KZR) has received a consensus rating of "Reduce" from six analysts, with two recommend

### [16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/282739590.md)
*2026-04-14T20:14:02.000Z*
> Halper Sadeh LLC is investigating Kezar Life Sciences, Equitable Holdings, and Urgent.ly for potential violations of fed

### [13:34 ETAre APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/282374434.md)
*2026-04-10T17:35:44.000Z*
> Halper Sadeh LLC is investigating Apellis Pharmaceuticals (APLS), Centessa Pharmaceuticals (CNTA), and Kezar Life Scienc

### [14:15 ETSHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS](https://longbridge.com/en/news/282082448.md)
*2026-04-08T18:17:22.000Z*
> Class Action Attorney Juan Monteverde is investigating mergers involving Kezar Life Sciences (KZR), Centessa Pharmaceuti